Phase III Study Testing Efficacy & Safety of Oral Dabigatran Etexilate vs Warfarin for 6 m Treatment for Acute Symp Venous Thromboembolism (VTE)

NCT00680186 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

2589

Enrollment

INDUSTRY

Sponsor class

Conditions

Thromboembolism

Interventions

DRUG: Warfarin
DRUG: Dabigatran etexilate

Sponsor

Boehringer Ingelheim